tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

ESSA Pharma Announces $80 Million Shareholder Distribution Amid Acquisition

Story Highlights
  • ESSA Pharma will distribute US$80 million to shareholders as part of its business winding-up.
  • The distribution precedes a transaction where XenoTherapeutics will acquire ESSA’s shares.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

WisdomTree India Earnings Fund ( (EPI) ) has provided an announcement.

ESSA Pharma Inc. has announced a cash distribution of US$80 million to its shareholders, following a court order authorizing a reduction in the capital of its common shares. This distribution is part of the company’s winding-up process and precedes a special meeting to approve a transaction with XenoTherapeutics, Inc., where Xeno will acquire all outstanding common shares. Shareholders are estimated to receive approximately US$1.91 per share, excluding contingent value rights payments. This move marks a significant shift in ESSA’s operations, as it transitions from its previous focus on prostate cancer therapies.

Spark’s Take on EPI Stock

According to Spark, TipRanks’ AI Analyst, EPI is a Neutral.

ESSA Pharma’s overall score reflects significant financial challenges with no revenue and ongoing losses. Technical indicators provide some positive signals, but caution is advised due to potential overbought conditions. The negative P/E ratio and lack of dividends further underline investment risks.

To see Spark’s full report on EPI stock, click here.

More about WisdomTree India Earnings Fund

ESSA Pharma Inc. is a pharmaceutical company that was previously focused on developing novel and proprietary therapies for the treatment of patients with prostate cancer.

Average Trading Volume: 944,527

Current Market Cap: $3.02B

For an in-depth examination of EPI stock, go to TipRanks’ Overview page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1